Market Overview

Inovio Pharmaceuticals, Inc. (AMEX: INO)

2.69 +0.05 (1.89%)

Analyst Ratings

DateResearch FirmActionCurrentPT
3/26/19Cantor FitzgeraldInitiates Coverage OnOverweight
10/02/18Stifel NicolausReinstatesBuy8.0
10/18/17RBC CapitalInitiates Coverage OnOutperform11.0
6/08/17PiperJaffrayUpgradesOverweight
3/16/17PiperJaffrayDowngradesNeutral9.0
11/07/16Aegis CapitalInitiates Coverage OnBuy
10/04/16Brean CapitalAssumesBuy18.0
8/09/16Maxim GroupDowngradesHold
3/14/16Brean CapitalMaintainsBuy18.0
3/12/15H.C. WainwrightInitiates Coverage onBuy17.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter